Yoshiro Ishiwata

1.3k total citations
19 papers, 1.0k citations indexed

About

Yoshiro Ishiwata is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Yoshiro Ishiwata has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Yoshiro Ishiwata's work include Immunotherapy and Immune Responses (5 papers), Chemokine receptors and signaling (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Yoshiro Ishiwata is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Chemokine receptors and signaling (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Yoshiro Ishiwata collaborates with scholars based in Japan, United States and United Kingdom. Yoshiro Ishiwata's co-authors include Kouji Matsushima, Hiroyuki Hashimoto, Kengo Furuichi, Naofumi Mukaida, Kiyoki Kitagawa, Takashi Wada, Hitoshi Yokoyama, Motohiro Takeya, William A. Kuziel and Masahide Asano and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Yoshiro Ishiwata

19 papers receiving 1.0k citations

Peers

Countries citing papers authored by Yoshiro Ishiwata

Since Specialization

Citations

This map shows the geographic impact of Yoshiro Ishiwata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiro Ishiwata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiro Ishiwata more than expected).

Fields of papers citing papers by Yoshiro Ishiwata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiro Ishiwata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiro Ishiwata. The network helps show where Yoshiro Ishiwata may publish in the future.

Co-authorship network of co-authors of Yoshiro Ishiwata

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiro Ishiwata. A scholar is included among the top collaborators of Yoshiro Ishiwata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiro Ishiwata. Yoshiro Ishiwata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Combining an Alarmin HMGN1 Peptide with PD-L1 Blockade Results in Robust Antitumor Effects with a Concomitant Increase of Stem-Like/Progenitor Exhausted CD8+ T Cells 2021 ·Cancer Immunology Research ·Chang-Yu Chen, Satoshi Ueha, Yoshiro Ishiwata, Shigeyuki Shichino, Shoji Yokochi, De Yang, Joost J. Oppenheim, Haru Ogiwara, (unknown), (unknown), Hiroyasu Aoki, Tatsuro Ogawa, Shiro Shibayama, Kouji Matsushima	24
2	Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust anti-tumor effects in mice 2019 ·Journal for ImmunoTherapy of Cancer ·Chang-Yu Chen, Satoshi Ueha, Yoshiro Ishiwata, Shoji Yokochi, De Yang, Joost J. Oppenheim, Haru Ogiwara, Shigeyuki Shichino, (unknown), Francis H. W. Shand, Shiro Shibayama, Kouji Matsushima	11
3	Combination of anti‐CD4 antibody treatment and donor lymphocyte infusion ameliorates graft‐versus‐host disease while preserving graft‐versus‐tumor effects in murine allogeneic hematopoietic stem cell transplantation 2017 ·Cancer Science ·Satoshi Ueha, Shoji Yokochi, Yoshiro Ishiwata, Mizuha Kosugi‐Kanaya, Yusuke Shono, Shiro Shibayama, Satoru Ito, Kouji Matsushima	1
4	Robust Antitumor Effects of Combined Anti–CD4-Depleting Antibody and Anti–PD-1/PD-L1 Immune Checkpoint Antibody Treatment in Mice 2015 ·Cancer Immunology Research ·Satoshi Ueha, Shoji Yokochi, Yoshiro Ishiwata, Haru Ogiwara, (unknown), Takuya Nakajima, (unknown), Shigeyuki Shichino, Yuya Terashima, Etsuko Toda, Francis H. W. Shand, Kazuhiro Kakimi, Satoru Ito, Kouji Matsushima	60
5	Abstract 265: Robust anti-tumor effects of combined anti-CD4 depleting antibody and anti-PD-1/PD-L1 immune checkpoint antibody treatment in mice 2015 ·Cancer Research ·Satoru Ito, Kouji Matsushima, Satoshi Ueha, Shoji Yokochi, Yoshiro Ishiwata, (unknown), Haru Ogiwara, (unknown), T. Nakajima	2
6	Discovery, Optimization, and Pharmacological Characterization of Novel Heteroaroylphenylureas Antagonists of C−C Chemokine Ligand 2 Function 2011 ·Journal of Medicinal Chemistry ·Edgardo Laborde, (unknown), Fanying Meng, (unknown), (unknown), (unknown), Reyna J. Simon, (unknown), (unknown), Hideaki Inagaki, Yoshiro Ishiwata, Takahito Jomori, (unknown), Atsushi Miyachi, Takashi Nakamura, Masayuki Okamoto, Tracy M. Handel, Claude C.A. Bernard	21
7	Abscopal Effect of Radiation Therapy and Signal Transduction 2010 ·Current Signal Transduction Therapy ·Kenshiro Shiraishi, Keiichi Nakagawa, Yuzuru Niibe, Yoshiro Ishiwata, Shoji Yokochi, Kuni Ohtomo, Kouji Matsushima	3
8	Enhancement of Antitumor Radiation Efficacy and Consistent Induction of the Abscopal Effect in Mice by ECI301, an Active Variant of Macrophage Inflammatory Protein-1α 2008 ·Clinical Cancer Research ·Kenshiro Shiraishi, Yoshiro Ishiwata, Keiichi Nakagawa, Shoji Yokochi, (unknown), Teruo Akuta, Kuni Ohtomo, Kouji Matsushima, Takuya Tamatani, Shiro Kanegasaki	90
9	Blockade of CCR2 Ameliorates Progressive Fibrosis in Kidney 2004 ·American Journal Of Pathology ·Kiyoki Kitagawa, Takashi Wada, Kengo Furuichi, Hiroyuki Hashimoto, Yoshiro Ishiwata, Masahide Asano, Motohiro Takeya, William A. Kuziel, Kouji Matsushima, Naofumi Mukaida, Hitoshi Yokoyama	277
10	Gene Therapy via Blockade of Monocyte Chemoattractant Protein-1 for Renal Fibrosis 2004 ·Journal of the American Society of Nephrology ·Takashi Wada, Kengo Furuichi, Norihiko Sakai, Yasunori Iwata, Kiyoki Kitagawa, Yuko Ishida, Toshikazu Kondo, Hiroyuki Hashimoto, Yoshiro Ishiwata, Naofumi Mukaida, Naohisa Tomosugi, Kouji Matsushima, Kensuke Egashira, Hitoshi Yokoyama	141
11	Long-term Treatment with Propagermanium Suppresses Atherosclerosis in WHHL Rabbits 2003 ·Journal of Cardiovascular Pharmacology ·Eto Y, Hiroaki Shimokawa, Eriko Tanaka, Kunio Morishige, Masahiro Fuchigami, Yoshiro Ishiwata, Kouji Matsushima, Akira Takeshita	12
12	Gene Therapy Expressing Amino-Terminal Truncated Monocyte Chemoattractant Protein-1 Prevents Renal Ischemia-Reperfusion Injury 2003 ·Journal of the American Society of Nephrology ·Kengo Furuichi, Takashi Wada, Yasunori Iwata, Kiyoki Kitagawa, K. Kobayashi, Hiroyuki Hashimoto, Yoshiro Ishiwata, Naohisa Tomosugi, Naofumi Mukaida, Kouji Matsushima, Kensuke Egashira, Hitoshi Yokoyama	84
13	CCR2 Signaling Contributes to Ischemia-Reperfusion Injury in Kidney 2003 ·Journal of the American Society of Nephrology ·Kengo Furuichi, Takashi Wada, Yasunori Iwata, Kiyoki Kitagawa, (unknown), Hiroyuki Hashimoto, Yoshiro Ishiwata, Masahide Asano, Hui Wang, Kouji Matsushima, Motohiro Takeya, William A. Kuziel, Naofumi Mukaida, Hitoshi Yokoyama	203
14	Non-steroidal anti-inflammatory drug, nabumetone, prevents indometacin-induced gastric damage via inhibition of neutrophil functions 2003 ·Journal of Pharmacy and Pharmacology ·Yoshiro Ishiwata, Masayuki Okamoto, Shoji Yokochi, Hiroyuki Hashimoto, Takashi Nakamura, Atsushi Miyachi, Yuji Naito, Toshikazu Yoshikawa	7
15	An Anti-Inflammatory Drug, Propagermanium, May Target GPI-Anchored Proteins Associated with an MCP-1 Receptor, CCR2 2001 ·Journal of Interferon & Cytokine Research ·Shoji Yokochi, Hiroyuki Hashimoto, Yoshiro Ishiwata, Hiroaki Shimokawa, Makoto Haino, Yuya Terashima, Kouji Matsushima	53
16	ChemInform Abstract: Synthesis and Antiinfluenza Virus Activity of Tricyclic Compounds with a Unique Amine Moiety. 2001 ·ChemInform ·Mitsuru Oka, Yoshiro Ishiwata, Noriyuki Iwata, (unknown), (unknown)	5
17	Synthesis and Anti-influenza Virus Activity of Tricyclic Compounds with a Unique Amine Moiety. 2001 ·Chemical and Pharmaceutical Bulletin ·Mitsuru Oka, Yoshiro Ishiwata, Noriyuki Iwata, (unknown), (unknown)	11
18	Stimulation of antiviral activities of interferon by a liver extract preparation. 1997 ·PubMed ·(unknown), Yoshiro Ishiwata, Hidetsugu Saito, Hirotoshi Ebinuma, Masaharu Tsuchiya, Hiromasa Ishii	5
19	Biosynthesis of different gangliosides in two types of rat ascites hepatoma cells with different degrees of cell adhesiveness 1979 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Takao Taki, Yoshio Hirabayashi, Yoshiro Ishiwata, Makoto Matsumoto, (unknown)	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact